trending Market Intelligence /marketintelligence/en/news-insights/trending/9BITM_p5WMBIAt3Rarn5tA2 content esgSubNav
In This List

EMERAM Capital-backed Meona buys pharmacy software provider Dr. Heni

Blog

Banking Essentials Newsletter: July Edition - Part 3

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

Banking Essentials Newsletter: July Edition - Part 2


EMERAM Capital-backed Meona buys pharmacy software provider Dr. Heni

EMERAM Capital Partners GmbH-backed Meona GmbH purchased Dr. Heni SOFTWARE GmbH & Co. KG for an undisclosed amount.

Dr. Heni Software, through its software products ZENZY and A-Taxe, supports hospitals and pharmacies in the production and billing of medicines and cytostatics drugs, which are natural or synthetic substances that inhibit cell growth or cell division.

Meona has been a portfolio company of EMERAM since 2017. EMERAM is a private investment firm focused on medium-sized businesses in German-speaking countries in the sectors of consumer goods, retail, industrial goods, business services and healthcare.

Dr. Heni Software founder Josef Heni was advised by Dr. Heni und Partner Steuerberater Rechtsanwälte PartGmbB, while Meona was advised by Friedrich Graf von Westphalen. Tax advice was provided by Melzer und Kollegen.